United States · Funded startup

Who invested in Cero Therapeutics

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$8.0Mraised across 1 round since 2025, from 1 source

Latest round
Round, $8.0MApr 2025
Investors
2
See who backed them

The rounds

  1. Apr 2025
    Round$8.0M

    Source recordedSEC filing: $5.0M sold, first sale Apr 2025

Founders and team

From the SEC filings it signed: 3 on the team.

  • Daniel Mark CoreyExecutive Officer, Director, Promoteri
  • Jordan CoreyExecutive Officer, Promoteri
  • Lawrence CoreyExecutive Officer, Promoteri

On the board, as filediHeather Mark TurnerStan Mark RiddellStuart Mark Sloan

Everyone who backed them

HSGVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Cero Therapeutics

Who invested in Cero Therapeutics?

Cero Therapeutics's investors include HSG and ARCH Venture Partners.

How much has Cero Therapeutics raised?

Cero Therapeutics has raised $8.0M across 1 round since 2025.

When did Cero Therapeutics last raise?

Cero Therapeutics's most recent round was an Undisclosed round of $8.0M in Apr 2025.

What was Cero Therapeutics's biggest round?

Its most recent round, $8.0M in Apr 2025, is also its largest on record.

Who backed Cero Therapeutics first?

Cero Therapeutics's first round on record, in Apr 2025, was backed by HSG and ARCH Venture Partners.

What stage is Cero Therapeutics at?

Cero Therapeutics's latest named round is an Undisclosed round, in Apr 2025.

Where is Cero Therapeutics based?

Cero Therapeutics is based in the United States.

Companies like Cero Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.